Literature DB >> 12463739

Influence of breast cancer on thymic function in mice.

Diana M Lopez1, Vijaya Charyulu, Becky Adkins.   

Abstract

The thymus is the major site of T cell maturation; extensive proliferation, differentiation, and apoptosis occur in this organ. During mammary tumorigenesis, there is a profound involution of the thymus associated with a severe depletion of the most abundant subset of thymocytes, CD4+8+ immature cells. Experiments to investigate the mechanism of loss of the CD4+8+ population indicated that there was no increase in the systemic levels of glucocorticoids, no loss of bone marrow precursors, and no decrease in precursor seeding of the thymus. Likewise, no enhanced emigration of thymocytes from the thymus to the periphery was observed in tumor-bearing mice. A slight increase in apoptosis was found in tumor bearers' thymi, but there was no apparent decrease in the proliferation of early thymic precursors CD4-8- cells. Importantly, severely altered levels of subpopulations of the CD4-8- precursors, consistent with an arrest in differentiation at an early stage of development, were detected. Moreover, thymic stromal cell function appeared to become impaired during tumorigenesis, possibly due to the action of tumor-derived factors. Thus, downregulation of cell-mediated immune functions occurring at late stages of the disease may be causally related to the thymic involution occurring during mammary tumorigenesis.

Entities:  

Mesh:

Year:  2002        PMID: 12463739     DOI: 10.1023/a:1020356020542

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  35 in total

1.  Early block in maturation is associated with thymic involution in mammary tumor-bearing mice.

Authors:  B Adkins; V Charyulu; Q L Sun; D Lobo; D M Lopez
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

Review 2.  The aging immune system: primer and prospectus.

Authors:  R A Miller
Journal:  Science       Date:  1996-07-05       Impact factor: 47.728

Review 3.  Down-regulation of the antitumor immune response.

Authors:  R J North
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

4.  Thymocyte apoptosis induced by elevated endogenous corticosterone levels.

Authors:  J Gruber; R Sgonc; Y H Hu; H Beug; G Wick
Journal:  Eur J Immunol       Date:  1994-05       Impact factor: 5.532

5.  Thymus-derived glucocorticoids regulate antigen-specific positive selection.

Authors:  M S Vacchio; J D Ashwell
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

6.  Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.

Authors:  J E Slansky; F M Rattis; L F Boyd; T Fahmy; E M Jaffee; J P Schneck; D H Margulies; D M Pardoll
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

7.  Thymic atrophy induced by murine mammary adenocarcinoma in vivo.

Authors:  Y X Fu; N Altman; D M Lopez
Journal:  In Vivo       Date:  1989 Jan-Feb       Impact factor: 2.155

8.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

Review 9.  The functional and histological basis for graft-versus-host-induced immunosuppression.

Authors:  W S Lapp; T Ghayur; M Mendes; M Seddik; T A Seemayer
Journal:  Immunol Rev       Date:  1985-12       Impact factor: 12.988

10.  Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.

Authors:  R D Paul; A Ghaffar; M M Sigel; V Charyulu; D M Lopez
Journal:  Anticancer Res       Date:  1981       Impact factor: 2.480

View more
  5 in total

Review 1.  Thymic Function Associated With Cancer Development, Relapse, and Antitumor Immunity - A Mini-Review.

Authors:  Weikan Wang; Rachel Thomas; Olga Sizova; Dong-Ming Su
Journal:  Front Immunol       Date:  2020-04-30       Impact factor: 7.561

2.  Tumor Arrests DN2 to DN3 Pro T Cell Transition and Promotes Its Conversion to Thymic Dendritic Cells by Reciprocally Regulating Notch1 and Ikaros Signaling.

Authors:  Ipsita Guha; Avishek Bhuniya; Divanshu Shukla; Ashok Patidar; Partha Nandi; Akata Saha; Shayani Dasgupta; Nilanjan Ganguly; Sweta Ghosh; Arathi Nair; Subrata Majumdar; Bhaskar Saha; Walter J Storkus; Rathindranath Baral; Anamika Bose
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

3.  Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.

Authors:  Hyo Min Ahn; JinWoo Hong; Chae-Ok Yun
Journal:  Oncotarget       Date:  2016-12-20

Review 4.  Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings.

Authors:  Mounika U L Goruganthu; Anil Shanker; Mikhail M Dikov; David P Carbone
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

5.  Huisheng Oral Solution exerts anti-tumor effects by downregulating tissue factor and inhibiting the expression of metastasis-related factors, CD44, MMP2, and VEGF.

Authors:  Zhonghua Chen; Mei Liu; Kaiyong Xie; Haitao Chen; Jun Wang; Xing Liu
Journal:  Transl Cancer Res       Date:  2019-11       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.